| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $137K | -98.3% |
| Cost of Revenue | $131K | -97.7% |
| Gross Profit | $6K | -99.8% |
| R&D Expense | $2.2M | — |
| SG&A Expense | $6.7M | +139.7% |
| Operating Income | -$14.7M | -102.4% |
| Pre-tax Income | -$18.8M | -121.4% |
| Income Tax | -$534K | — |
| Net Income | $9.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $11K | -98.6% |
| Inventory | $968 | +0.0% |
| Current Assets | $6.3M | +129.0% |
| Total Assets | $104.9M | +736.6% |
| Current Liabilities | $7.9M | -31.6% |
| Long-term Debt | $2.9M | — |
| Total Liabilities | $25.8M | +115.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.3M | -541.1% |
| Capital Expenditures | $12K | — |
| Investing Cash Flow | $27.6M | — |
| Financing Cash Flow | -$13.0M | -1023.0% |
| Free Cash Flow | -$14.3M | — |
| +150.8% |
| EPS (Basic) | $2.69 | +111.5% |
| EPS (Diluted) | $2.48 | +133.1% |
| Stockholders' Equity |
| $79.1M |
| — |